0000950170-24-010904.txt : 20240202
0000950170-24-010904.hdr.sgml : 20240202
20240202203110
ACCESSION NUMBER: 0000950170-24-010904
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Turtle Cameron
CENTRAL INDEX KEY: 0001758363
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37722
FILM NUMBER: 24593630
MAIL ADDRESS:
STREET 1: C/O EIDOS THERAPEUTICS, INC.
STREET 2: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spyre Therapeutics, Inc.
CENTRAL INDEX KEY: 0001636282
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BUILDING 23, SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 6176515940
MAIL ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BUILDING 23, SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: Aeglea BioTherapeutics, Inc.
DATE OF NAME CHANGE: 20150311
4
1
ownership.xml
4
X0508
4
2024-02-01
0001636282
Spyre Therapeutics, Inc.
SYRE
0001758363
Turtle Cameron
221 CRESCENT STREET, BUILDING 23,
SUITE 105
WALTHAM
MA
02453
true
true
false
false
Chief Executive Officer
false
Stock Option (Right to Buy)
25.86
2024-02-01
4
A
false
277750
0.00
A
2034-02-01
Common Stock
277750
277750
D
This option represents a right to purchase 277,750 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.
/s/ Heidy King-Jones, as Attorney-in-Fact
2024-02-02